Earlens Corporation
PrivateLast Round
Series E
Apr 17, 2024
Total Funding Raised
$379.57M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Earlens Corporation is a medical technology company that develops and commercializes the Earlens Contact Hearing System, a prescription hearing device that uses light to directly vibrate the eardrum.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Earlens Corporation Comparables
Compare Earlens Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ototronix | 80% | |
| Envoy Medical, Inc. | 79% | |
| Starkey | 74% |
Earlens Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Apr 17, 2024 | ||||
| Convertible Debt | Apr 14, 2022 | ||||
| VC Round | Aug 25, 2021 | ||||
| VC Round | Jan 7, 2021 | ||||
| Series D | Oct 22, 2018 | ||||
Series C | Jun 5, 2017 |
Earlens Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KCK MedTech | Series D |
| Vertex Ventures HC | Series D, Series C |
| Relativity Healthcare Partners | Series D |
| New Enterprise Associates | Series D, Series C, VC Round, Series B |
| Lightstone Ventures | Series D, Series C, Series B |
| Andrew W. Mellon Foundation | Series D |
| Baltisches Haus Limited | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Plans to open four new clinic locations across San Diego County.
- May 15, 2025
Collaborating to build an automated referral program for customer acquisition.
Earlens Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Earlens Corporation's valuation, stock price, and market status.
Is Earlens Corporation a public or private company?
Earlens Corporation is a private company.
What is the current stock price of Earlens Corporation?
Earlens Corporation is a private company, so its shares have no public market price. Caplight tracks Earlens Corporation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Earlens Corporation worth (valuation)?
Valuation information for Earlens Corporation is not publicly available.
Can I buy Earlens Corporation stock?
Earlens Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Earlens Corporation's last funding round?
Earlens Corporation's most recent funding round was Series E on April 17, 2024.
Who are the main investors in Earlens Corporation?
Key investors in Earlens Corporation include KCK MedTech, Vertex Ventures HC, New Enterprise Associates, KCK FZE, CRG.
Will Earlens Corporation IPO soon?
No public IPO plans have been announced for Earlens Corporation.
How can I track Earlens Corporation secondary market activity?
Caplight tracks bids, offers, and trades in Earlens Corporation's shares on secondary markets.